Publications by authors named "Helena Florindo"

Claim this Profile
A
A rationally designed polypeptide-based hybrid platform for targeted intranasal brain drug delivery.
Inmaculada Conejos-Sánchez, Tetiana Melnyk, Esther Masiá, Daniel Morelló-Bolumar, Luz Tortajada-Comeche, Helena Florindo

Biomaterials· May 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment.
Bárbara Carreira, Rita C Acúrcio, Ana I Matos, Liane I F Moura, Marta B Afonso, Helena F Florindo

J Control Release· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation-guided nanoparticles enhance the efficacy of PARP inhibitors in primary and metastatic BRCA1-deficient tumors via immunotherapy.
Rami Khoury, Giuseppe Longobardi, Tania T Barnatan, Dana Venkert, América García Alvarado, Helena F Florindo

J Control Release· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing sulfur-doped carbon nanodots conjugated with IDO inhibitors act as a dual-mode breast cancer immunotherapy.
Roberta Cillari, Rita C Acúrcio, Andreia Barateiro, Helena F Florindo, Nicolò Mauro

J Control Release· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-The-Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against Melanoma.
Liane If Moura, Alessio Malfanti, Ana I Matos, Carina Peres, Ana Armiñán, Helena F Florindo

Adv Mater· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural insights and clinical advances in small-molecule inhibitors targeting TGF-β receptor I.
Carlota Leonardo-Sousa, Rodrigo Barriga, Helena F Florindo, Rita C Acúrcio, Rita C Guedes

Mol Ther Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer.
Cláudio Ferro, Ana I Matos, Luigia Serpico, Flavia Fontana, Jacopo Chiaro, Helena F Florindo

Adv Healthc Mater· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative Tumour Volume in Canine Oral Melanoma Staging and Prognosis.
Marta L Silva, Inês Martinho, Margarida Rocha, Marina Martano, Kevin P Spindler, Helena F Florindo

Vet Comp Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancers.
Shani Koshrovski-Michael, Daniel Rodriguez Ajamil, Pradip Dey, Ron Kleiner, Shahar Tevet, Helena F Florindo

Sci Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Better, Faster, Stronger: Accelerating mRNA-Based Immunotherapies With Nanocarriers.
Henrique M B Carvalho, Tiago A S Fidalgo, Rita C Acúrcio, Ana I Matos, Ronit Satchi-Fainaro, Helena F Florindo

Wiley Interdiscip Rev Nanomed Nanobiotechnol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy.
Rita C Acúrcio, Ron Kleiner, Daniella Vaskovich-Koubi, Bárbara Carreira, Yulia Liubomirski, Helena F Florindo

Adv Sci (Weinh)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Gateways to the brain: vascular-glial-immune network in health and disease.
Diana Matias, Patrícia P Garcez, Helena Florindo, Luis Graça, Luiz Gustavo Dubois

Front Cell Neurosci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy.
Carina Peres, Ana I Matos, Bárbara Carreira, Liane I F Moura, Ron Kleiner, Helena F Florindo

Adv Funct Mater· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissue.
Saumya Kumar, Afonso P Basto, Filipa Ribeiro, Silvia C P Almeida, Patricia Campos, Helena F Florindo

Cell Discov· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1 Analogue-Loaded Glucose-Responsive Nanoparticles as Allies of Stem Cell Therapies for the Treatment of Type I Diabetes.
Joana Moreira Marques, Rute Nunes, Ana Margarida Carvalho, Helena Florindo, Domingos Ferreira

ACS Pharmacol Transl Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors.
Ana I Matos, Carina Peres, Barbara Carreira, Liane I F Moura, Rita C Acúrcio, Helena F Florindo

Adv Sci (Weinh)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant .
David Pires, Manoj Mandal, Ana I Matos, Carina Peres, Maria João Catalão, Helena F Florindo

Antibiotics (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Highlights in nano-based drug delivery 2021/22.
Santosh Kumar, Helena F Florindo, Gianfranco Pasut

Front Med Technol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression.
Sabina Pozzi, Anna Scomparin, Dikla Ben-Shushan, Eilam Yeini, Paula Ofek, Helena F Florindo

JCI Insight· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment.
Rita C Acúrcio, Sabina Pozzi, Barbara Carreira, Marta Pojo, Nuria Gómez-Cebrián, Helena F Florindo

J Immunother Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically-relevant and predictive cancer models for nanomedicine evaluation.
Ronit Satchi-Fainaro, Helena F Florindo, María J Vicent

Adv Drug Deliv Rev· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current hurdles to the translation of nanomedicines from bench to the clinic.
Snežana Đorđević, María Medel Gonzalez, Inmaculada Conejos-Sánchez, Barbara Carreira, Sabina Pozzi, Helena F Florindo

Drug Deliv Transl Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics.
Cláudio Ferro, Helena F Florindo, Hélder A Santos

Adv Healthc Mater· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System.
Carlos Rodolfo, Dalinda Eusébio, Cathy Ventura, Renato Nunes, Helena F Florindo

Pharmaceutics· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical models and technologies to advance nanovaccine development.
Carina Peres, Ana I Matos, Liane I F Moura, Rita C Acúrcio, Barbara Carreira, Helena F Florindo

Adv Drug Deliv Rev· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis